• About
  • Disclaimer
  • Helpful Info on Writing Theses/Research
  • Resources

a1000shadesofhurt

a1000shadesofhurt

Tag Archives: misdiagnosis

Body dysmorphic disorder: charity video reveals the image anxieties that can push people to the edge

11 Monday May 2015

Posted by a1000shadesofhurt in Body Image

≈ Leave a comment

Tags

anxiety, appearance, BDD, body dysmorphic disorder, cbt, Depression, diagnosis, distress, isolation, medication, misdiagnosis, physical appearance, professionals, suicide

Body dysmorphic disorder: charity video reveals the image anxieties that can push people to the edge

It is a treatable condition suffered by at least 2% of the population, both male and female, that devastates the lives of those who have it and can lead to prolonged depression and even suicide. Now a fledgling charity, the Body Dysmorphic Disorder Foundation, hopes to raise awareness of the obsessive anxiety condition that leaves people convinced there is something flawed or “ugly” about their looks.

The foundation’s first conference, on 30 May in London, is aimed at health professionals, body dysmorphic disorder (BDD) sufferers and their carers, and is being promoted by a two-minute film, You Are Not Alone, directed by Steve Caplin, which tackles one of the greatest issues surrounding BDD: the idea that the person with it is isolated and cannot fit in.

“One of the biggest problems is that this is an under-researched disorder which is not fully understood by either professionals or laymen,” says clinical psychologist Dr Annemarie O’Connor, director of themindworks, a London-based psychology practice, who will be running a workshop at the conference. “This is not simply a case of feeling low or having to change your clothes a couple of times before you go out. It’s an obsessive anxiety disorder which can lead to huge levels of distress.”

That distress in turn can lead to prolonged bouts of depression and often suicide. “There’s such a high level of hopelessness and a real conviction among sufferers that they are ugly to look at or flawed,” explains O’Connor.

“Many sufferers turn to cosmetic intervention, but when that doesn’t change how they feel or how they see themselves. They become utterly convinced that a better way doesn’t exist, and this makes suicide a real feature of the disorder.”

Robert Pattinson, who was catapulted to fame after getting the role of vampire Edward Cullen in the Twilight films, told Australia’s Sunday Style magazine that he suffers from anxiety and BDD issues, which can become crippling before a red-carpet event.

“I get a ton of anxiety, right up until the second I get out of the car to the event, when suddenly it completely dissipates,” said Pattinson. “But up until that moment I’m a nutcase. Body dysmorphia, overall tremendous anxiety. I suppose it’s because of these tremendous insecurities that I never found a way to become egotistical. I don’t have a six-pack and I hate going to the gym. I’ve been like that my whole life. I never want to take my shirt off.”

Scarlett Bagwell’s 19-year-old daughter, Alannah, first began exhibiting signs of BDD at the age of 14. “I noticed that she had lost a lot of weight fast and at first I thought it was anorexia, but then other things began to happen – she would refuse to come out with us, didn’t want to leave her room … I still thought it might be teenage angst, but then one day she dropped out of school, despite having always loved it.

“There was so much turmoil in her head – she couldn’t get on the bus, I’d drive her to school but she wouldn’t go in. She really wanted to, but she couldn’t physically get out of the car. She’s a beautiful girl, but she was convinced there was so much wrong with her – she’d insist that her nose was too big and deformed, that she had tiny, piggy eyes and funny hair.”

As Alannah’s condition worsened, including bouts of self-harm and suicide attempts, so her family struggled to get a diagnosis. “I had to fight the system to get the proper treatment for her,” says her mother. “Just getting a diagnosis was so hard and meanwhile Alannah went from being very independent to being a baby again. At times I even had to force her to wash and I would wash her hair for her. Everything was a struggle. I felt I was failing my daughter.”

The hard-won key to her recovery was a combination of cognitive behavioural therapy (CBT) specifically tailored for BDD sufferers and anti-depression medication.

Alannah is now sitting her A/S exams at a local college and intends to go to university. Her mother hopes that the establishment of a regular conference will lead to further understanding, help and support for those with BDD. “I think that because everybody has slight issues with their appearance – they don’t like their hair, or they think a particular dress makes them look bad – they can’t understand the struggle that actual body dysmorphics go through,” she says. “It stops you functioning. People with body dysmorphia are very isolated; they often can’t bring themselves to go out, no matter how much they want to, they don’t want to be seen.

“We were lucky that Alannah has had help and the support of her family, but I wonder how many people struggle without that support because they are diagnosed later, undiagnosed or misdiagnosed,” she said.

A group of neuroscientists believes it can communicate with “locked-in” coma patients

21 Monday Apr 2014

Posted by a1000shadesofhurt in Neuroscience/Neuropsychology/Neurology

≈ Leave a comment

Tags

'vegetative state'; 'trapped'; coma, awakefulness, awareness, Brain activity, brain imaging, brain injury, brain scans, cognitive processing, communication, conscious, diagnosis, families, fMRI, Locked-In Syndrome, misdiagnosis, powerlessness, recovery, reflex, relatives

A group of neuroscientists believes it can communicate with “locked-in” coma patients

“Imagine you wake up, locked inside a box,” says Adrian Owen.”It’s a perfect fit, down to every last one of your fingers and toes. It’s a strange box because you can listen to absolutely everything going on around you, yet your voice cannot be heard. In fact, the box fits so tightly around your face and lips that you can’t speak, or make a noise. At first, this feels like a game. Then reality sets in. You see and hear your family lamenting your fate. You’re too cold. Then too hot. You’re always thirsty. The visits of your friends and family dwindle. Your partner moves on. And there’s nothing you can do about it.”

Owen and I are talking on Skype. I’m sitting in London while he’s at the University of Western Ontario in Canada. Owen’s reddish hair and close-cropped beard loom large on my screen as he becomes animated describing the torment of those with no voice: his patients.

People in a “vegetative state” are awake yet unaware. Their eyes can open and sometimes wander. They can smile, grasp another’s hand, cry, groan or grunt. But they are indifferent to a hand clap, unable to see or understand speech. Their motions are not purposeful but reflexive. Their minds remain firmly shut. Still, when their eyelids flutter open, you are always left wondering if there’s a glimmer of consciousness.

A decade ago, the answer would have been a bleak and emphatic no. Not any longer. Using brain scanners, Owen has found that some may be trapped inside their bodies yet able to think and feel to varying extents. The number of these cases has soared in recent decades, ironically, because doctors have steadily become better at saving patients with catastrophic injuries.

Today, trapped, damaged and diminished minds inhabit clinics and nursing homes worldwide – in Europe alone, the number of new coma cases is estimated to be 230,000 annually, of whom 30,000 will languish in a persistent vegetative state. They are some of the most tragic and expensive artefacts of modern intensive care.

Owen knows this only too well. In 1997, a close friend set off on her usual cycle to work. Anne had a weak spot on a blood vessel in her head, known as a brain aneurysm. Five minutes into her trip, the aneurysm burst and she crashed into a tree. She never regained consciousness.

The tragedy of Anne’s accident would shape Owen’s life. He began to wonder if there was a way to determine which of these patients were in an unconscious coma, which were conscious and which were somewhere in between?

That year, he had moved to the Medical Research Council’s Cognition and Brain Sciences Unit in Cambridge, where researchers used various scanning techniques. One, positron emission tomography (PET), highlights different metabolic processes in the brain, such as oxygen and sugar use. Another, known as functional magnetic resonance imaging (fMRI), can reveal active centres in the brain by detecting the tiny surges in blood flow that take place as a mind whirrs. Owen wondered whether he could use these technologies to reach out to patients, like his friend, stuck between sensibility and oblivion.

Today, being alive is no longer linked to having a beating heart, explains Owen. If you are on a life-support machine, are you dead? Is a failure to sustain independent life a reasonable definition of death? No, otherwise we would all be “dead” in the nine months before birth.

The issue becomes murkier when we consider those trapped in the twilight worlds between normal life and death – from those who slip in and out of awareness, who are trapped in a “minimally conscious state”, to those who are severely impaired in a vegetative state or a coma.

In the wake of the development of the artificial respirator during the 1950s in Denmark, pioneering work to categorise disorders of consciousness was carried out in the 1960s by the neurologist Fred Plum in New York and the neurosurgeon Bryan Jennett in Glasgow.

Plum coined the term “locked-in syndrome”, in which a patient is aware and awake but cannot move or talk. With Plum, Jennett devised the Glasgow Coma Scale to rate the depth of coma, and Jennett followed up with the Glasgow Outcome Scale to weigh up the extent of recovery, from death to mild disability. Together they adopted the term “persistent vegetative state” for patients who, they wrote, “have periods of wakefulness when their eyes are open and move; their responsiveness is limited to primitive postural and reflex movements of the limbs, and they never speak”. In 2002, Jennett was among a group of neurologists who chose the phrase “minimally conscious” to describe those who are sometimes awake and partly aware, who show erratic signs of consciousness so that at one time they might be able to follow a simple instruction and at another they might not.

Kate Bainbridge, a 26-year-old schoolteacher, lapsed into a coma three days after she came down with a flu-like illness. A few weeks after her infection had cleared, Kate awoke from the coma but was diagnosed as being in a vegetative state. Luckily, the intensive-care doctor responsible for her, David Menon, was also a principal investigator at the newly opened Wolfson Brain Imaging Centre in Cambridge, where Adrian Owen then worked.

Menon wondered whether elements of cognitive processing might be retained in patients in a vegetative state, and discussed with Owen how to use a brain scanner to detect them. In 1997, four months after she had been diagnosed as vegetative, Kate became the first patient in such a state to be studied by the Cambridge group. The results, published in 1998, were extraordinary. Her brain responses were indistinguishable from those of healthy volunteers; her scans revealed brain activity at the back of her brain, in a part which helps recognise faces. Kate became the first such patient in whom sophisticated brain imaging (in this case PET) revealed “covert cognition”. Of course, whether that response was a reflex or a signal of consciousness was, at the time, a matter of debate.

The results were of huge significance not only for science but also for Kate and her parents. “The existence of preserved cognitive processing removed the nihilism that pervaded the management of such patients in general, and supported a decision to continue to treat Kate aggressively,” recalls Menon.

Kate eventually surfaced from her ordeal, six months after the initial diagnosis. She described how she was indeed sometimes aware of herself and her surroundings. “They said I could not feel pain,” she says. “They were so wrong.”

Sometimes she’d cry out, but nurses thought it was nothing more than a reflex. Hospital staff had no idea how much she suffered in their care. Physiotherapy nurses never explained what they were doing to her. She was terrified when they removed mucus from her lungs. “I can’t tell you how frightening it was, especially suction through the mouth,” she has written. Her pain and despair became such that she tried to snuff out her life by holding her breath. “I could not stop my nose from breathing, so it did not work. My body did not seem to want to die.”

Kate says her recovery was not so much like turning on a light but a gradual awakening. By then she had lost her job, her sense of smell and taste, and much of what might have been a normal future. Now back with her parents, Kate is still very disabled and needs a wheelchair. Yet, 12 years after her illness, she started to talk again and, though still angry about the way she was treated when she was at her most vulnerable, she remains grateful to those who helped her mind to escape.

She sent Owen a note:

“Dear Adrian, please use my case to show people how important the scans are. I want more people to know about them. I am a big fan of them now. I was unresponsive and looked hopeless, but the scan showed people I was in there. It was like magic, it found me.” k

Nicholas Schiff is a neurologist at Weill Cornell Medical College in New York. His working life is a balancing act between putting the interests of his patients and their families first and keeping true to the science as he wrestles with disorders of consciousness. “There’s a lot we don’t know,” he admits. “Frankly, I am wrong a lot of the time.”

In 2005, Schiff applied his emerging understanding of the circuits of consciousness to Jim, a 38-year-old man who had been beaten and robbed and was left minimally conscious. Jim’s eyes had mostly remained shut. He was unable to speak and could communicate only by a nod, or tiny eye or finger movements. His plight seemed hopeless. Eventually, Jim’s mother gave a “do not resuscitate order” to doctors. Schiff thought differently.

Schiff had earlier scanned Jim with fMRI in 2001. His team had played subjects, including Jim, an audiotape in which a relative or loved one reminisced. In detailed fMRI scans, Jim had shown that, despite having a very underactive brain, he had preserved large-scale language networks. When he heard a story that meant something to him, his brain lit up. What, thought Schiff, if Jim’s thalamus could be activated by deep brain stimulation?

A brain pacemaker was implanted into Jim. After its two electrodes delivered pulses of electricity to his thalamus, he was able to use words and gestures, respond reliably to requests, eat normally, drink from a cup, and carry out simple tasks such as brushing his hair. Schiff believes that once a brain re-engages with the world, it accelerates processes of repair. For the next six years, before Jim died of unrelated causes, he kept his mind above the minimally conscious state. “He could converse in short sentences reliably and consistently and make his wishes known,” says Schiff. “He could chew and swallow and eat ice-cream and hang out. His family told us that they had him back.” The case made the front page of the New York Times. “I prayed for a miracle,” his mother told me at the time he was brought back. “The most important part is that he can say ‘Mummy and Pop, I love you.’ God bless those wonderful doctors. I still cry every time I see my son, but it is tears of joy.”

In a forested campus south of Liège, Steven Laureys studies vegetative patients in research that dates back decades. Working there as part of the Cyclotron Research Centre in the 1990s, he was surprised when PET brain scans revealed that the patients could respond to a mention of their own name. Meanwhile, on the other side of the Atlantic, Nicholas Schiff was finding that partially working regions lay within catastrophically injured brains. What did it all mean?

At that time, doctors thought they already knew the answers: no patient in a persistent vegetative state was conscious. Medical practitioners, with the best intentions, thought it was perfectly acceptable to end the life of a vegetative patient by starvation and the withdrawal of water. This was the age of what Laureys calls “therapeutic nihilism”.

What Owen, Laureys and Schiff were proposing was a rethink of some of the patients who were considered vegetative. A few of them could even be classed as being fully conscious and locked-in. The establishment was doggedly opposed. “The hostility we encountered [in the late 1990s] went well beyond simple scepticism,” says Schiff. Looking back, Laureys pauses and smiles thinly: “Medical doctors do not like to be told they are wrong.”

Then came 2006. Owen and Laureys were trying to find a reliable way to communicate with patients in a vegetative state, including Gillian. In July 2005, this 23-year-old had been crossing a road, chatting on her mobile phone. She was struck by two cars and diagnosed as vegetative.

Five months later, a strange piece of serendipity allowed Gillian to unlock her box. “I just had a hunch,” says Owen. “I asked a healthy control [subject] to imagine playing tennis. Then I asked her to imagine walking through the rooms of her house.” Imagining tennis activates part of the cortex called the supplementary motor area, involved in the mental simulation of movements. But imagining walking around the house activates the parahippocampal gyrus in the core of the brain, the posterior parietal lobe, and the lateral premotor cortex. So, if people were asked to imagine tennis for “yes” and walking around the house for “no”, they could answer questions via fMRI.

Gazing into Gillian’s “vegetative” brain with the brain scanner, he asked her to imagine the same things – and saw strikingly similar activation patterns to the healthy volunteers. It was an electric moment. Owen could read her mind.

Gillian’s case, published in the journal Science in 2006, made front-page headlines around the world. The result provoked wonder and, of course, disbelief. “Broadly speaking, I received two types of email from my peers,” says Owen. “‘This is amazing – well done!’ and ‘How could you possibly say this woman is conscious?'”

As the old saw goes, extraordinary claims require extraordinary evidence. The sceptics suggested that it was wrong to make these “radical inferences” when there could be a more straightforward interpretation. Daniel Greenberg, a psychologist at the University of California, Los Angeles, suggested that, “the brain activity was unconsciously triggered by the last word of the instructions, which always referred to the item to be imagined”.

Parashkev Nachev, a neurologist now at University College London, says he objected to Owen’s 2006 paper not on grounds of implausibility or a flawed statistical analysis but because of “errors of inference”. Although a conscious brain, when imagining tennis, triggers a certain pattern of activation, it does not necessarily mean the same pattern of activation signifies consciousness. The same brain area can be activated in many circumstances, Nachev says, with or without any conscious correlate. Moreover, he argues that Gillian was not offered a true choice to think about playing tennis. Just as a lack of response could be because of an inability to respond or a decision not to co- operate, a direct response to a simple instruction could be a conscious decision or a reflex.

What is needed is less philosophising and more data, says Owen. A follow-up study published in 2010 by Owen, Laureys and colleagues tested 54 patients with a clinical diagnosis of being in a vegetative state or a minimally conscious state; five responded in the same way as Gillian. Four were supposedly in a vegetative state at admission.

Owen, Schiff and Laureys have explored alternative explanations of what they observed and, for example, acknowledge that the brain areas they study when they interrogate patients can be activated in other ways. But the 2010 paper ruled out such automatic behaviours as an explanation, they say: the activations persist too long to signify anything other than intent. “You cannot communicate unconsciously – it is just not possible,” says Owen. “We have won that argument”.

Since Owen’s 2006 Science paper, studies in Belgium, the UK, the US and Canada suggest that a significant proportion of patients who were classified as vegetative in recent years have been misdiagnosed – Owen estimates perhaps as many as 20 per cent. Schiff, who weighs up the extent of misdiagnosis a different way, goes further. Based on recent studies, he says around 40 per cent of patients thought to be vegetative are, when examined more closely, partly aware. Among this group of supposedly vegetative patients are those who are revealed by scanners to be able to communicate and should be diagnosed as locked-in, if they are fully conscious, or minimally conscious, if their abilities wax and wane.

There is anecdotal evidence that when contact is re-established with the occupant of a living box they are understandably morose, even suicidal. They have been ground down by frustration at their powerlessness, over the months, even years, it can take to recognise their plight. Yet the human spirit is resilient, so much so that they can become accustomed to life in this twilight state. In a survey of patients with locked-in syndrome, Laureys has found that when a line of communication is set up, the majority become acclimatised to their situation, even content (again, these insights took time to be accepted by the medical and scientific establishment – and even to be published in a scientific journal – reflecting the prevailing unease about the implications for hospitals and care homes).

The important question is detecting the extent to which such patients are conscious. Studies of large numbers of patients with brain injuries, and how they fare over the years, show that it makes a huge difference to the chance of recovery if a patient is minimally conscious rather than vegetative. The former have fragmentary understanding and awareness and may recover enough to return to work within a year or two.

Yet there are still surprises, such as the case of New York fireman Don Herbert, who awoke after a decade from a minimally conscious state caused by a severe brain injury suffered while fighting a fire in 1995. Schiff has used a technique called diffusion tensor imaging to show how a brain can rewire itself even decades after an injury – yet in the past year, even he has recommended withdrawing care from a man who had lain in a coma for eight weeks after a cardiac arrest. “I was wrong,” he says. “This man is now back at work.”

Parashkev Nachev has not changed his view since he first criticised Owen’s work, and spelt out the basis of his unease in a more detailed paper published in 2010. “For every relative of a living PVS [persistent vegetative state] patient given (probably false) hope, another is burdened with the guilt of having acquiesced in the withdrawal of treatment from someone who – he has been led to believe – may have been more alive than it seemed,” he says. “There are moral costs to false positives as well as to false negatives.

“I find the whole media circus surrounding the issue rather distasteful. The relatives of these patients are distressed enough as it is.”

Laureys, Owen and Schiff spend a great deal of time with the families and understand these sensitivities only too well. Owen counters that, from his years of experience dealing with the families, they are grateful that doctors and scientists take an interest and are doing everything they can. “These patients have been short-changed over the years,” he insists.

Owen is adamant that doctors have a moral duty to provide a correct diagnosis, even if the results cause guilt, unease or distress. “We must give every patient the best chance of an accurate diagnosis, so we can give them the appropriate care that goes along with that diagnosis.”

Under the umbrella classification of “vegetative” lies a vast array of brain injuries and, as a result, even some of the most vocal critics accept that some vegetative patients are not as diminished as traditional measures suggest. Professor Lynne Turner-Stokes chairs a group for the Royal College of Physicians that is revising UK guidelines on “Prolonged Disorders of Consciousness”. She remains unconvinced that the exceptional cases identified by Owen, Laureys and Schiff are particularly common or that enough has been done to establish brain scanners as a standard tool for routine diagnosis, particularly when the cost and convenience of these methods are taken into account. When it comes to extending these tests to all patients in a vegetative states as standard practice, “The evidence is just not there yet,” she says.

But she stresses that she is simply being cautious, not sceptical, describing the work of Owen, Laureys and Schiff as “important and exciting”. “We are only just beginning to scratch the surface,” she says. “But I have no doubt [these techniques] will have a place, eventually, in the evaluation of patients.”

Back on Skype, Owen smiles, considering whether to tell me what he is planning next. His partner, Jessica Grahn, also a neuroscientist, became pregnant at the start of 2013. What happens when consciousness winks on in the developing brain? He emails me a video of their unborn child, a montage of fMRI slices through their baby’s head, as it twists and turns in Jessica’s womb. “My colleagues have been doing fMRI on my wife’s tummy every week for a few weeks now to see if we can activate the foetus’s brain,” he writes. “It is amazing.”

Some names have been changed to protect identities. Adrian Owen’s friend Anne remains in a vegetative state. Adrian Owen and Jessica Grahn’s baby boy was born on 9 October 2013.

Cancer’s lost generation: the teens and young adults ‘forgotten in the middle’

16 Monday Dec 2013

Posted by a1000shadesofhurt in Cancer, Young People

≈ Leave a comment

Tags

diagnosis, misdiagnosis, teenagers, Young adults, young people

Cancer’s lost generation: the teens and young adults ‘forgotten in the middle’

After six months of misdiagnosis, Stephen was eventually told he had bowel cancer. He was 15. A straight-A student, he had always wanted to be a doctor. Now 18, he says: “I’ve lost faith in the healthcare system.” He visited his GP numerous times with “crippling symptoms” and went to A&E on five occasions. “I have a strong family history ofbowel cancer. At one point, we asked the doctor if I might have cancer and demanded further scans. He said: ‘No, definitely not, you’re too young.'”

Over the past three decades, cancer survival rates have increased dramatically. But for teenagers and those in their 20s, the outlook is less promising – several reports have shown that improvements in outcomes for them do not match those among children and older adults.

To investigate this, the National Institute for Health Research has launched Brightlight, a cohort study that hopes to become the largest ever of young cancer patients (aged 13-24). It intends to recruit more than 2,000 people by next April. In earlier studies, two of its leaders, Professor Jeremy Whelan, a specialist in teenage oncology atUniversity College London Hospital, and Dr Lorna Fern of the National Cancer Research Institute, found that one of the critical factors for the “survival deficit” is delayed or mis-diagnosis. Invariably, this leads to a poorer prognosis as the more advanced the cancer is, the harder it is to treat.

According to a study published in the BMJ in October this year, those aged 16 to 25 are twice as likely as older adults to have three or more GP consultations before being referred to a specialist and a 2010 survey found more than a quarter of young cancer patients had visited their GP at least four times, many presenting with multiple “alert”symptoms (lumps, swellings or persistent unexplained pain) before their eventual referral. More than a third of participants at this year’s Teenage Cancer Trust (TCT) conference (the aptly named Find Your Sense of Tumour) were only diagnosed on emergency. Among many young patients there is overwhelming resentment of GPs; a sense that they were not taken seriously, their symptoms dismissed as adolescent fatigue, stress, or persistent hangovers.

It is true that cancer is rare among young people. But it is also the leading medical cause of non-accidental death among them – and the TCT says that in the past 30 years, cancer among teens and young adults has risen by 50%; for the first time, teenage cancer cases outnumber those of children. Young people are also known to contract the most aggressive forms, exacerbated by their growth spurts. Failure to detect the warning signs at an early stage can have devastating consequences, as Stephen’s case shows; his cancer was recently diagnosed as incurable. Raising awareness, he says, is essential to dispel the myth that young people are immune – a situation not helped by NHS campaigns such as Be Clear on Cancer, which feature only older faces.

Greater awareness is also needed to enable GPs to spot the “alarm-bell” symptoms. Since younger patients tend to develop the rarer forms of cancer – leukaemias, lymphomas, sarcomas, germ-cell tumours and cancers of the central nervous system – there is an urgent need for more research to group the specific symptoms of these malignancies.

At the moment, teens and young adults are also seriously under-represented in clinical trials. In a 2008 study, Whelan and Fern found almost half of patients aged 10-14 participated in a trial, but this fell to 25.2% for 15 to 19-year-olds, and just 13.1% for those aged 20-24. For too long, they argue, clinical and research communities have failed to recognise teens and young adults as a distinct category with unique biologies, and they have been left “forgotten in the middle”.

It is the same story when it comes to hospital care; teens and young adults have been identified as a “lost tribe”, caught between paediatric services and those designed for older patients. The National Cancer Reform Strategy (2007) estimated that 70% were not treated in age-appropriate settings; many were left on children’s wards, with the disturbance of crying babies, or isolated in bays with elderly patients and surrounded by constant bereavement.

Those lucky enough to be treated alongside their peers at a young-person unit describe the experience as a godsend. “I was a total mess before I found Teenage Cancer Trust,” says Jasmine Singh, 22, who is recovering from Hodgkin’s lymphoma. She was transferred to a TCT unit with specialist young-person cancer nurses and counsellors, as well as a team of support workers offering education and career advice – a lifeline for young sufferers who fall behind with their studies or training.

In 2005, government directives recommended that all 13 to 24-year-old cancer patients be treated in such units – but at the moment there are only 27 in the UK, and only around half of all young patients are treated in one. The same recommendations stressed the importance of “age-appropriate care”, but there is no real consensus over what this means. The Brightlight study sets out to provide some answers. By interviewing young adults over a five-year period, it aims to gain a clearer insight into the type of care that benefits them the most.

One of the study’s pioneers was Stephen himself, in his capacity as a young adviser at the National Cancer Research Institute. “I don’t know how long I have left because I haven’t asked,” he says. He refuses to waste a moment on self-pity – in between chemotherapy treatments, he is too busy fundraising for TCT, determined to improve the outlook for other young people with cancer.

Report reveals postcode lottery of care for children with epilepsy

24 Monday Sep 2012

Posted by a1000shadesofhurt in Neuroscience/Neuropsychology/Neurology, Young People

≈ Leave a comment

Tags

Children, diagnosis, epilepsy, fainting, family, medication, misdiagnosis, MRI scan, seizure, support, symptoms, young people

Report reveals postcode lottery of care for children with epilepsy

Children who suffer from epilepsy face a “profoundly concerning” variability in the quality of care they receive, depending on where they live, according to a new report published today.

Epilepsy, which can have a devastating impact on educational attainment and badly disrupt the lives of sufferers, is the most common serious neurological condition diagnosed in the UK affecting one in 200 children or around 60,000 youngsters.

Charities called for urgent action after the first national audit of epilepsy services for young people found that barely half of families are offered the support of a qualified epilepsy nurse within a year of their child being diagnosed. The role is seen as vital in monitoring medication, advising schools that can be overly restrictive of children with the condition, and providing support to parents.

England offered the worst level of specialist nursing support, according to the survey of children’s NHS services conducted by the Royal College of Paediatrics and Child Health. Only 47 per cent of units offered the service – compared with 77 per cent in Wales, 73 per cent in Scotland and 100 per cent in Northern Ireland.

Half of children diagnosed with epilepsy do not achieve their full educational potential, said the report’s author, consultant paediatrician Dr Colin Dunkley.

“We’ve seen marked steps forward in epilepsy care for children in recent years. The majority of children are now being seen by paediatricians with expertise and many are getting detailed diagnoses and being prescribed the most appropriate medicines first time. But there are certain areas that need to be improved if we’re to give children and young peopl e the best possible medical treatment and ongoing care.”

The report also found that a third of children were not adequately assessed at first, while more than seven out of 10 did not receive an MRI scan necessary to detect underlying causes of the condition.

Nearly half of those suffering from the more serious types of epilepsy did not see a paediatric neurologist when required, it was found.

Epilepsy is often very hard to diagnose with GPs and hospital emergency departments often lacking experience in recognising symptoms which can often be mistaken for fainting or other conditions

Dr Peter Carter, chief executive of the Royal College of Nursing said advances in care had transformed the lives of children. “However, it is a matter of profound concern to us that this is not the case everywhere,” he said.

David Ford, chief executive of the charity Young Epilepsy, added: “More must be done, and quickly, if we are ever to make meaningful improvements to these young lives. The support received by young people with epilepsy just simply is not good enough. The effects of the condition can be devastating and should not be underestimated.”

Case study: ‘Suddenly she was having 20 fits a day’

There was nothing spectacular about my daughter’s first fit. In fact it took several weeks before we realised she was having them at all.

“There was no falling to the floor, frothing at the mouth or flailing of limbs, rather a brief rolling of the eyes and a vacant look. It was all over in a matter of seconds. We were on holiday in Norfolk when we eventually clocked that this was beyond normal weird five-year-old behaviour. From occasionally zoning out, suddenly she was having 20 in a single day. It was absolutely terrifying and we rushed her to hospital where she was diagnosed with childhood absence seizure.

“Because Lucy has speech and language delay she already had a paediatrician in York who we were able to phone the next morning. She arranged an EEG test for three weeks time in which electrical receptors are attached to the head to monitor the pattern of brain waves during an induced fit.

“The results came through a week later and we are now two weeks into a course of medication which should put an end to her fits. We have had excellent, prompt care. Our paediatrician offered us the services of a specialist epilepsy nurse and we are due to have an MRI scan. Having read the report I now realise we are among the lucky ones.

Not just a boy thing: how doctors are letting down girls with autism

16 Monday Jul 2012

Posted by a1000shadesofhurt in Autism, Young People

≈ Leave a comment

Tags

aggression, anxiety, Depression, Eating Disorders, emotions, gender, mental health issues, misdiagnosis, OCD, relationships, social exclusion, stress, tics, vulnerability

Not just a boy thing: how doctors are letting down girls with autism

Annette Lewns has more experience than most of the different ways in which boys and girls with autism are treated. Her 14-year-old son, Ryan, was diagnosed when he was three and a half. But doctors refused to diagnose her 12-year-old daughter, Rachel, until she was nine.

“What angers me is that for years I was dismissed by doctors purely because Rachel was a girl. Ryan was spotted very quickly because the autism symptoms that doctors look for are so male-orientated,” said Lewns. “But Rachel’s autism was hidden unless you knew where to look for it.

“Rachel could express herself, she had a couple of friends and understood emotions if someone was at an extreme: really upset or really happy. But you didn’t really have to look too hard to see she didn’t genuinely understand emotions or relationships: she was just mimicking scripts and scenarios from TV.”

“The doctors failed time and time again to see through her coping strategies. I fought for years but I was confronted with a wall of disbelief and scepticism. They were simply unable to understand that a girl might present differently to a boy.”

While Ryan’s condition was acknowledged by their local authority, and he is now at a specialist school, Rachel continues to struggle at a mainstream school. “Ryan is being taught all sorts of tools and techniques to cope with his condition but Rachel is not,” said Lewns.

Estimates of the ratio of females to males diagnosed with Asperger’s syndrome or high-functioning autism varies from 1:4 to 1:10. No one understands this gender disparity: whether women really are less likely to be on the spectrum than men – or whether doctors are failing to spot the disorder in women.

Opinions are divided: Richard Mills, director of research at the National Autistic Society (NAS) says he “would not be surprised” if the true ratio was twice as high, with one woman on the spectrum for every two men. Dr Judith Gould, director of the NAS’s Lorna Wing Centre, thinks the ratio could be even narrower, with 1:1.5 female:male.

We may soon have an answer. Mills is leading the UK arm of a two-year international programme, Autism in Pink, which will look at the condition in women, focusing on the stress, social exclusion, vulnerability and misdiagnosis they suffer.

It follows concerns about reluctance to diagnose women. One recent survey by NAS found girls may wait longer than boys for a diagnosis and are more likely to be misdiagnosed: just one-fifth of girls with Asperger’s syndrome who responded to the survey were diagnosed by the age of 11, compared with half of boys.

The UK is leading the research side of the programme. Last week, Mills signed up the first two of the 12 women with Asperger’s he needs to work with researchers over a two-year period.

“I hope the programme will be the first step to ending the current trend for gender to be a barrier to diagnosis and post-diagnostic support,” he said. “Because research in the past has largely concentrated on males, the way we understand autism tends to be very much based on the experiences of men and boys with the condition. People are reluctant, for some reason, to make a diagnosis in girls and women.”

This reluctance is exacerbated by the fact that girls and women with Asperger’s or high-functioning autism can be more adaptive than boys: they are commonly better at hiding things or seeming more sociable, masking what doctors traditionally think of as the signs of autism.

But the strain of trying to appear “normal” can be immensely stressful. Gould said it results in “many of the girls we see having developed secondary problems such as anxiety, eating disorders or depression”.

This can also mean that misdiagnosis of girls and women is also a problem. The survey found 42% of females had been wrongly told they suffered psychiatric, personality or eating disorders, compared with 30% of males.

There is also the problem that the gender difference becomes a self-fulfilling prophecy: because more males are diagnosed than females, it is their symptoms and behaviours that experts have studied. The so-called screening tools, developed to help diagnosticians spot the syndrome, focus on culturally “male” interests, such as computers, trains and cars, rather than things more likely to appeal to a girl, such as animals, soap operas or fashion. Gould is rewriting the NAS’s diagnostic interview for social and communication disorders to include “gender-neutral” cues.

Even when an accurate assessment is given, however, it is no guarantee that the necessary support and help will materialise: the NAS survey found women continue to struggle after diagnosis, with half of females with Asperger’s or high-functioning autism – compared with 39% of males – saying it made no difference to the support they received.

Lucy Clapham, 25, spent years being turned away by doctors who insisted “girls don’t get autism” and told her to simply “act normal and read female magazines”. “I am certain that my diagnosis was delayed because of the fact that I am a girl,” she said. “My mum first noticed something when I was about six but our GP laughed at the suggestion. I’ve gone to counsellors, doctors and psychiatrists but all of them, including my teachers, refused to see I had classic autism even though I had casebook symptoms: almost no speech until I was five, no friends, hours spent staring at the washing machine, lining toys up and flicking my fingers in front of my eyes.”

When she was 12, Clapham became violent, aggressive and developed multiple tics, obsessions and compulsions. “I stopped talking outside of the house and sunk into an inner world,” she said.

After two more years and about eight counsellors, Clapham’s GP referred her to a child psychiatrist. “She was adamant that girls didn’t get autism, they just had ‘traits’,” said Clapham. “She claimed that I just needed to ‘act normal’ and that by buying nice clothes and reading women’s magazines I could learn to be ‘normal’. The only diagnosis I received from her was depression and anxiety.”

After leaving the children’s mental health service “none the wiser and possibly with more mental health problems than when I had arrived”, Clapham was sent to the adult mental health service and, after a long battle, to the Maudsley hospital in London, where she was finally diagnosed with autism, Tourette syndrome and obsessive-compulsive disorder.

“I was still refused services, however, partly because there were none available and partly because our local authority was not willing to fund an out-of-town, specialist autism service,” said Clapham. “I ended up getting sent to a college for the blind where I developed more mental health problems and became very aggressive because no one understood me or my autistic behaviour.

“When I was 20, I ended up in care because my mother couldn’t cope with my aggression and anxiety.”

Clapham stayed there for three years but still struggles. “Despite my diagnoses, some people still seem to believe that autism is a ‘boy thing’,” she said.

There is no clear understanding about how many girls and women are being missed – or wrongly diagnosed – and for how long. But that may soon change: the first neuroimaging analysis of women and men, with and without ASD, has been under way for the past two and a half years at King’s College’s Institute of Psychiatry (IoP) and the Autism Research Centre at the University of Cambridge. It’s hoped this research could provide the clues. The final stage of the project is about to begin, with results expected in months.

“It’s very exciting,” said Dr Michael Craig, a senior lecturer and honorary consultant at the IoP’s department of forensic and neurodevelopmental sciences. “We could well be looking at gender-specific treatments for Asperger’s being developed in quite a short period of time.”

What is autism?

First identified in the 1940s, autism is a developmental disability that lasts a lifetime and affects someone’s interaction with other people – how they communicate with and relate to them. It is a spectrum condition, affecting some more seriously than others. While some lead fairly independent lives, others suffer serious learning disabilities and need extensive support. Many who have an autism spectrum disorder can be badly affected because they have trouble processing sounds, sights and smells.

Around half a million people in the UK have autism, according to the National Autistic Society (NAS). What causes it is still unclear. “There is strong evidence to suggest that autism can be caused by a variety of physical factors, all of which affect brain development. It is not due to emotional deprivation or the way a person has been brought up,” the NAS says. Genetic factors are assumed to be responsible, and scientists are trying to pin down which genes are involved. Genetic testing to enable earlier diagnosis is therefore still a long way off.

Many people are not diagnosed until they reach adulthood. A recent NAS study of more than 8,000 people with autism, parents and carers found 52% were initially misdiagnosed. One in three adults with the condition say they have developed serious mental health problems because they have not received enough support to help them cope with the difficulties autism brings.

The Mass Production of Mental Illness and What To Do About It

01 Wednesday Feb 2012

Posted by a1000shadesofhurt in Psychiatry

≈ 1 Comment

Tags

'Anti-Psychiatry', 'AntiPsychiatry', cbt, chlorpromazine, diagnosis, drugs, DSM, ECT, Kraepelin, Laing, medication, Medicine, mental health issues, misdiagnosis, psychiatry, Rogers, Rosenhan, schizophrenia, Skinner, Szaza, treatment

The Mass Production of Mental Illness and What To Do About It

DOCTORING THE MIND: IS OUR CURRENT TREATMENT OF MENTAL ILLNESS REALLY ANY GOOD?
By Richard P. Bentall
NYU Press, 364 pages. $29.95

“Conventional psychiatry, which reached its zenith with the neo-Kraepelinian movement, has not only failed to deliver tangible benefits for patients (antipsychotics…were an accidental discovery) but has also failed to deliver a credible explanation of psychosis. It is not that there is a lack of biological evidence; rather, the evidence has been misinterpreted and shoehorned into a biomedical framework that fits it poorly. A radical new approach to understanding severe mental illness, which brings together the evidence on the social, psychological and biological causes of psychosis, is urgently required.”

In the 1960s, a movement called “antipsychiatry” (prompted in Britain by R. D. Laing and in the U.S. by Thomas Szazs) questioned the basic assumptions about mental illness and its treatment. Not only psychiatry, but methods popular earlier in the twentieth century, such as the prefrontal leucotomy, electroconvulsive therapy (ECT), and insulin coma therapy, lay thoroughly discredited. The anti-psychiatrists encouraged treating the patient as a whole person, putting his “madness” in the social and environmental context. Unfortunately, with the passage of the counterculture the medical establishment returned with a vengeance to explaining mental illness strictly as a manifestation of physical disorders of the brain and treating it with particular medications.

Dr. Richard P. Bentall, professor and practitioner of clinical psychology in Britain, who earlier wrote Madness Explained: Psychosis and Human Nature (2003), exposes the highly dubious nature of reigning presumptions about the causes and treatment of mental illness. He favors the “recovery-oriented, autonomy-promoting” model, particularly cognitive behavioral therapy, over the “paternalistic-medical” model, which favors reductionist diagnosis, genetic causation, and reliance on drugs to correct so-called “chemical imbalances.” Bentall explores why the biomedical approach has become dominant, instead of a social approach to madness, which was gaining traction in the 1960s. There is little evidence to show that psychiatric drugs are effective in the long run; by making spurious connections between damaged brains and drugs alleged to overcome such disfigurement, the medical profession ignores better treatment options.

In his important book The Rise and Fall of Modern Medicine (1999), James Le Fanu identifies twelve definitive moments in the history of medicine, one of which is the discovery of the drug chlorpromazine in the early 1950s. Over the long run, however, the medical profession has been manifestly unable to improve recovery outcomes for patients suffering from mental illness. A striking finding is that patients in developing countries, with much less health care expenditure per capita, recover better from schizophrenia than patients in developed countries. The accidental discovery of chlorpromazine by a French doctor must be viewed in the context of the state of psychiatric treatment, a shambles before the excitement caused by the new drugs. As Le Fanu concludes, “Why should a compound that blocks histamine in the tissues of the body also interfere with an entirely different chemical–dopamine–in the brain in a way that alleviates the symptoms of schizophrenia? What is schizophrenia? What is its cause? The map of mental illness, like that of Africa before the arrival of the Victorian explorers, remains a blank.” Medical discoveries have sharply fallen off since their post-World War II peak; both “The New Genetics” and “The Social Theory” (attributing disease to lifestyle choices) have failed to halt the rise of illness, particularly psychiatric illness.

Emil Kraepelin (1856-1926) is the key figure in the classification of psychiatric disorders, making a distinction between dementia praecox (senility of the young, later relabeled schizophrenia) and manic depression. The growth of mental asylums, particularly in the U.S., didn’t abate until the middle of the twentieth century. Also in parallel, extreme remedies including electroconvulsive therapy, prefrontal leucotomy, and insulin coma therapy became popular. Walter Freeman, the American evangelist for prefrontal leucotomy, used “a hammer to tap an ice-pick-like instrument placed above the eyeball and against the orbital bone behind,” after which “he would move…[the instrument] from side to side in order to produce the desired lesion.” Rosemary Kennedy, sister of President John F. Kennedy, was a famous victim of Freeman: “a woman who had perhaps suffered from mild intellectual impairment, but who could read and write…was left incontinent and able to utter only a few words.” In insulin coma therapy, patients’ “brains were starved of glucose,” and they would slip into a coma. Brain-cell death, and the desired catatonic state, resulted.

Contesting behavior modification programs, articulated by pioneers B. F. Skinner (author ofWalden Two) and Carl Rogers, varied in their approaches to control versus autonomy, but the impact of innovation remained limited in the asylums and clinics. David Rosenhan published a famous paper in Science in 1972, called “On being sane in insane places,” throwing doubt on the supposed empirical nature of psychiatric diagnoses. With seven other “pseudo-patients,” Rosenhan showed up at psychiatric clinics pretending to have symptoms of schizophrenia. Staff at the hospitals were unable to change their diagnostic presuppositions to match the pseudo-patients’ perfectly normal behavior once admitted: “A pseudo-patient waiting outside a cafeteria half an hour before it opened (there was nothing else to do) was described by one psychiatrist as having an ‘oral acquisitive syndrome.’ When observed making notes, another was said to exhibit ‘obsessive writing behavior.'” Interestingly, the patients picked up that the pseudo-patients were journalists or professors.

Meanwhile, unable to rise to the challenge posed by Thomas Szazs’s groundbreaking The Myth of Mental Illness (1960), psychiatrists doubled down on the idea that there is something “wrong with the brains of mentally ill patients.” Thus came about the “chemical-imbalance explanation for mental illness, an idea that was to prove more potent in the minds of ordinary people than anything dreamed up by the antipsychiatrists.” In other words, even as Freudian assumptions about the unconscious, the role of sexuality, and repressed fantasies were being discredited, the science of biological psychiatry emerged to put forth the idea that “too much dopamine at the [brain synapses]…causes schizophrenia,” and that “an imbalance in the neurotransmitter serotonin” causes depression. Note that these two ideas are at the basis of every psychiatric drug peddled since the 1960s, and if they can be thrown into doubt, so can the efficacy of all the drugs currently on the market. Certainly, the drug companies’ interests (as Marcia Angell, above all, has pointed out in her work) are well-served, but can we say the same for patients? Even the president of the American Psychiatric Association lamented in 2005: “As a profession, we have allowed the biopsychosocial model [of mental illness] to become the bio-bio-bio model.”

The new biological researchers styled themselves neo-Kraepelinians, and the American Psychiatric Association’s landmark Diagnostic and Statistical Manual-III (DSM), issued in 1980 and since then further revised, is a monument to Kraepelin in sharply distinguishing between the normal and the sick, in separating discrete categories of mental illnesses, and in focusing on the biological approach to mental illness. If each of these dubious propositions can be shown to be weak or even false, then the entire edifice of current psychiatric practice also collapses. Neuroscience, not any sort of talking therapy, was to be the panacea; “manipulating neurotransmitters, not…understanding and interpreting the patients’ thoughts and feelings,” was what young psychiatrists should learn. Has the DSM led to more accurate diagnoses than was the case before? Lauren Slater, in Opening Skinner’s Box: Great Psychological Experiments of the Twentieth Century (2004), describes replicating Rosenhan’s experiment by presenting herself as a patient at psychiatric emergency rooms.

Now to the dismantling of each of the three key propositions upon which present psychiatric practice rests. First, are psychiatric diagnoses meaningful? The concepts of both dementia praecox (schizophrenia) and manic depression, first proposed by Kraepelin, have undergone repeated transformations over the last century, with allied growth in various neuroses (anxiety disorders), subdivided into many classes. The DSM sought to achieve consistency in psychiatric diagnoses, but precision remains spurious. A significant obstacle to precision, according to Bentall, is comorbidity; often patients suffering one psychiatric illness seem to suffer from others as well, which keep shifting in intensity over time. As Bentall concludes damningly, “If the same drugs work for everyone, the diagnosis given to the patient has virtually no implications at all.”

Second, as to the boundary between the “sick” and the “normal,” many people have psychotic symptoms without requiring treatment. Schizophrenia is best perceived on a continuum, rather than as the dark side of a clear dividing line between normality and a lifetime of helplessness. In recent years, psychiatrists have desperately sought to preserve the structure of diagnostic precision by resorting to increasing “fractionation,” for example of the “bipolar spectrum into bipolar 3 disorder, bipolar 4 disorder, and so on.” Schizophrenia and bipolar disorder, instead of being thought of as ‘real conditions,” might be better seen as ‘scientific delusions.”

The third fundamental error of psychiatry follows from the “neo-Kraepelinian… assumption that psychiatric disorders are genetically determined diseases that are little influenced by the trials of life.” The most that can be argued is that “genes play some role at some point in increasing the risk of mental illness, but nothing else.” Bentall explains that “the only findings that have proved to be even marginally replicable concern genes that confer only a very small risk of psychosis and which are absent in the majority of patients” and that “if there were any genes with more direct and marked effects, they would have certainly been discovered by now.” It is important to consider that “not a single…[patient] has ever benefited from genetic research into mental illness.”

Yet current psychiatric practice prefers unchanging genetic influence over environmental factors–particular stresses and traumas in life–in aggravating mental illness. As Bentall argues, “Insecure attachment and victimization appear to contribute to paranoia, sudden trauma appears to cause hallucinations, and parental communication deviance has been implicated in thought disorder.” Yet the psychiatrist’s job these days is focused on getting the patient to agree to a discrete diagnosis, followed by quick agreement to take the prescribed medication. At the research level, psychiatric geneticists are busy trying to identify specific genes involved in schizophrenia, bipolar disorder, and other conditions–a fool’s errand, if ever there was one, since the venture is premised on ignoring environmental influences.

The neo-Kraepelinians, i.e., the majority of the psychiatric profession today, have been obsessed with reliance on CT scans, and more recently MRI’s, to locate the exact sites of brain disease. Yet even if dopamine neurones are involved in paranoia, it stands to reason that “the nervous system of an animal living the life of repeated victimization will become highly attuned to the detection of further threatening events.” So it is reasonable to think that “the dopamine system becomes sensitized as a consequence of adverse experiences that predate the onset of illness,” rather than being the cause.

The excessive profits of drug companies–“in 2002, the combined profits for the ten [largest] drug companies…[exceeded]…the profits of all the other 490 companies put together”–can be explained by our unreasonable expectations about what medical science can deliver. In The Role of Medicine: Dream, Mirage or Nemesis (1979), Thomas McKeown argues that most of the “health gains achieved during the nineteenth and early twentieth centuries were the consequence, not of advances in medical science, but of improvements in nutrition and sanitation.” This concept leads to the recent global movement embracing evidence based medicine, which, Bentall argues, has so far not affected the psychiatric profession. Big Pharma continues to exploit loopholes in the concept of the randomized controlled trial (RCT), to adduce greater effectiveness for drugs than warranted.

In the late 1980s, SSRI’s (serotonin re-uptake inhibitors), represented by Prozac, became immensely popular. The drug industry made extravagant claims for their effectiveness. Yet “subsequent metaanalyses have reported that nearly all of the therapeutic response to both the old and new antidepressants can be attributed to the placebo effect.” Drug company data, submitted to the FDA in support of licensing applications, is kept secret, but when occasionally it comes to light severe problems of duration, size, and sample become manifest. For example, data from “47 trials of the six most popular new antidepressants…[shows] that the most rigorous of the studies had examined the patients for a mere eight weeks without any attempt to find out what happened to them afterwards, and that drop-out rates were so high that only 4 out of the 47 were able to report what happened to more than 70 percent of the patients.” In short, psychotic drug trial data cannot be trusted.

Rather than adhere to the Hippocratic Oath of “first do no harm,” psychiatrists are recently pushing for the earliest possible intervention–lifetime prescription of psychotic drugs–based on the manifestation of pre-symptoms, rather than actual illness, and for the inclusion of the widest possible population in such prescreening. Contrary to this drive, studies have shown that “first-episode…patients benefit less from…treatment than patients who have been ill for some time.” Big Pharma and psychiatrists also claim that so-called second-generation drugs have fewer side effects, but many studies show that this is clearly not true. Of even more concern is the fact that long-term administration of psychotic drugs may worsen symptoms because of “the proliferation of the number of D2 receptors in the brain”–in other words, “the brain responds to having its dopamine receptors blocked by making more of them.”

If drugs have been oversold, what is to be done then? Cognitive behavior therapy (CBT), which seeks to alter negative thought patterns, is one approach. It may or may not be more effective than other forms of psychotherapy, but at least it shows more respect for the patient than condemning him to a lifetime of medication, and making him feel useless because of irremediable genetic dysfunction in the brain. Many patients can manage the symptoms of schizophrenia without having to be condemned or committed. The aim should be to help patients improve their quality of life, rather than relying on bright-line distinctions between normality and illness. In the “paternalistic-medical” model, patients’ preferences about treatment are ignored because their judgment is not trusted; in the “autonomy-promoting” model Bentall advocates, patients are actively involved in deciding the course of treatment. Bentall offers a neat schematic splitting the two models along the axes of principal advocates, beliefs about mental illness, attitude toward diagnosis, goals of treatment, attitude towards patients’ judgments, attitude towards treatment, attitude towards the therapeutic alliance, attitude towards risk and coercion, and attitude towards medical skills that sharply distinguishes the polarities between the two approaches.

At stake in this debate is the utilitarian (Benthamite) versus deontological (Kantian) ethic. Both moral philosophies emphasize individual rights, the Kantians in particular arguing that individuals should always be treated as ends in themselves, rather than as means to ends. Present psychiatric practice, heading as it is toward condemning large swaths of the population to a perpetual sentence of mental deviance, doesn’t even match the less rigorous scales of utilitarianism when it comes to individual autonomy. The present model is based on coercion, and coercion is wrong on several counts as an approach to mental illness.

Joanna Moncrieff, in The Myth of the Chemical Cure: A Critique of Psychiatric Drug Treatment(2008), has pointed out that we should free ourselves of the delusion that there can be specific drugs for discrete mental illnesses. She demonstrates that “a majority of the published trials show that antidepressants are a bit better than placebo, but despite the many possible biases which make positive results more likely, many studies found that antidepressants were no better than placebo and some found that they were worse.” She also shows how “decades of research have failed to produce clear and independent evidence of a dopamine abnormality in people with psychosis or schizophrenia that cannot be attributed to some other cause” and that “there is little evidence to suggest that there is a characteristic abnormality in [the serotonin and noradrenalin]…systems that is associated with depression.” Instead, Moncrieff argues that “the early marketing campaigns for antidepressants had to establish the idea of depression as a common, medically treatable condition”–the more common, the better, from the drug companies’ point of view.

In addition to recognizing the limitations of drugs, more emphasis needs to be placed on the sociological roots of depression (as Bentall points out, the majority of mentally ill patients tend to be unemployed, and employment tends to assist in recovery). Psychiatry, since the early 1950s, has stalled; the revolutionary impetus of the 1960s is gone; the profession needs to reboot, and start treating people again as people, not as “plants.” The motivation behind the new drugs remains the same as it was for the radical remedies of electroconvulsive therapy, prefrontal leucotomy, and insulin coma therapy.

Recent Posts

  • Gargoyles, tarantulas, bloodied children: Research begins into mystery syndrome where people see visions of horror
  • Prosopagnosia
  • How mental distress can cause physical pain

Top Posts & Pages

  • Gargoyles, tarantulas, bloodied children: Research begins into mystery syndrome where people see visions of horror
  • Prosopagnosia
  • How mental distress can cause physical pain

Enter your email address to follow this blog and receive notifications of new posts by email.

Archives

  • February 2022
  • August 2020
  • May 2017
  • February 2017
  • August 2016
  • April 2016
  • November 2015
  • August 2015
  • June 2015
  • May 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011

Categories

  • Adoption
  • Autism
  • Body Image
  • Brain Injury
  • Bullying
  • Cancer
  • Carers
  • Depression
  • Eating Disorders
  • Gender Identity
  • Hoarding
  • Indigenous Communities/Nomads
  • Military
  • Miscarriage
  • Neuroscience/Neuropsychology/Neurology
  • Older Adults
  • Postnatal Depression
  • prosopagnosia
  • Psychiatry
  • PTSD
  • Refugees and Asylum Seekers
  • Relationships
  • Self-Harm
  • Sexual Harassment, Rape and Sexual Violence
  • Suicide
  • Trafficking
  • Uncategorized
  • Visual Impairment
  • War Crimes
  • Young People

Meta

  • Register
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.com

Blogroll

  • Freedom From Torture Each day, staff and volunteers work with survivors of torture in centres in Birmingham, Glasgow, London, Manchester and Newcastle – and soon a presence in Yorkshire and Humberside – to help them begin to rebuild their lives. Sharing this expertise wit
  • GET Self Help Cognitive Behaviour Therapy Self-Help Resources
  • Glasgow STEPS The STEPS team offer a range of services to people with common mental health problems such as anxiety and depression. We are part of South East Glasgow Community Health and Care Partnership, an NHS service. We offer help to anyone over the age of 16 who n
  • Mind We campaign vigorously to create a society that promotes and protects good mental health for all – a society where people with experience of mental distress are treated fairly, positively and with respect.
  • Research Blogging Do you write about peer-reviewed research in your blog? Use ResearchBlogging.org to make it easy for your readers — and others from around the world — to find your serious posts about academic research. If you don’t have a blog, you can still use our
  • Royal College of Psychiatrists Mental health information provided by the Royal College of Psychiatrists
  • Young Minds YoungMinds is the UK’s leading charity committed to improving the emotional well being and mental health of children and young people. Driven by their experiences we campaign, research and influence policy and practice.

Blog at WordPress.com.

  • Follow Following
    • a1000shadesofhurt
    • Join 100 other followers
    • Already have a WordPress.com account? Log in now.
    • a1000shadesofhurt
    • Customize
    • Follow Following
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar